FDA Inspection 1227454 — James B Harris III MD
The FDA completed an inspection of James B Harris III MD on Dec 22, 2023 in South Bend, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 22, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- South Bend, IN (United States)
Additional Details
Clinical Investigator (CI)